These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. IgE multiple myeloma: a report of the third case. Fishkin BG; Orloff N; Scaduto LE; Borucki DT; Spiegelberg HL Blood; 1972 Mar; 39(3):361-7. PubMed ID: 4621803 [No Abstract] [Full Text] [Related]
4. [Immunoglobulins gamma D (IgD) and gamma E (IgE). Structure, function and clinical importance]. Götz H; Kirschbaum R Med Klin; 1971 Dec; 66(51):1749-57. PubMed ID: 5004306 [No Abstract] [Full Text] [Related]
5. Immunoglobulin E (IgE) multiple myeloma: a case report and review of the literature. Endo T; Okumura H; Kikuchi K; Munakata J; Otake M; Nomura T; Asakawa H Am J Med; 1981 May; 70(5):1127-32. PubMed ID: 7015852 [TBL] [Abstract][Full Text] [Related]
6. A case of IgE multiple myeloma. Lloyd L; Klingberg SL; Kende M; Howell JF; Clague AE Pathology; 2003 Feb; 35(1):87-9. PubMed ID: 12701695 [No Abstract] [Full Text] [Related]
7. A case of IgE myeloma: methodology and review of the literature. Allevato PA; Deegan MJ; Chu JW; Perry MB; Barth CL Henry Ford Hosp Med J; 1984; 32(2):134-41. PubMed ID: 6439692 [No Abstract] [Full Text] [Related]
8. Diclonal and multiple gammopathies. Ottó S; Puskás E; Medgyesi GA; Gergely J Haematologia (Budap); 1972; 6(4):471-87. PubMed ID: 4206675 [No Abstract] [Full Text] [Related]
9. Sensitivity in detection of monoclonal immunoglobulins by thin-layer isoelectric focusing and certain electrophoreses in laboratory use. Kamiya-Harada Y; Sato Y; Otani H; Kawakami M Microbiol Immunol; 1981; 25(10):1067-76. PubMed ID: 7311884 [TBL] [Abstract][Full Text] [Related]
10. The IgG subclass distribution in 659 myeloma sera. Skvaril F; Morell A; Barandun S Vox Sang; 1972 Dec; 23(6):546-51. PubMed ID: 4632944 [No Abstract] [Full Text] [Related]
11. Isolation of immunochemically pure IgE from serum of E-myeloma patient Yu. Stefani DV; Gusev AI; Mokeeva RA Immunochemistry; 1973 Aug; 10(8):559-61. PubMed ID: 4202730 [No Abstract] [Full Text] [Related]
12. [Myelomatous paraproteinemia of the IgA or IgG type and blood lipids]. Clerc M; Triquet A; Martine J Bull Soc Pathol Exot Filiales; 1974; 67(1):101-8. PubMed ID: 4219146 [No Abstract] [Full Text] [Related]
13. IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia. Chiu W; Pullon H; Woon ST; Oei P; The R; Ameratunga R Pathology; 2010 Jan; 42(1):82-4. PubMed ID: 20025486 [No Abstract] [Full Text] [Related]
14. IgE myeloma: a case presentation and a review of the literature. Kairemo KJ; Lindberg M; Prytz M Scand J Clin Lab Invest; 1999 Oct; 59(6):451-6. PubMed ID: 10612556 [TBL] [Abstract][Full Text] [Related]
15. Technical aspects of the detection and characterization of immunoglobulin dyscrasis. Conway BP Health Lab Sci; 1972 Jul; 9(3):185-96. PubMed ID: 4625660 [No Abstract] [Full Text] [Related]
16. [A case of IgD myeloma]. Erroz A; Arroyo MJ; Díaz-Rubio C; Palomo ML Rev Clin Esp; 1973 Nov; 131(4):331-4. PubMed ID: 4772785 [No Abstract] [Full Text] [Related]
17. "Benign" monoclonal IgE gammopathy. Ludwig H; Vormittag W Br Med J; 1980 Aug; 281(6239):539-40. PubMed ID: 7427360 [TBL] [Abstract][Full Text] [Related]
18. Serum immunoglobulin E levels in patients with neoplastic disease. Waldmann TA; Bull JM; Bruce RM; Broder S; Jost MC; Balestra ST; Suer ME J Immunol; 1974 Jul; 113(1):379-86. PubMed ID: 4208923 [No Abstract] [Full Text] [Related]